Question 1
A 45-year-old male with paroxysmal atrial fibrillation and a normal left ventricular ejection fraction returns to the clinic. He is currently taking metoprolol but complains of severe fatigue during marathon training that prevents him from running. Which pharmacological intervention is most appropriate?
▸ Why A is the answer
Beta-blockers are excellent first-line agents for rate control, but they frequently cause generalized fatigue and significantly blunt the heart rate response during vigorous physical activity. For a highly active patient experiencing exercise intolerance, switching to a non-dihydropyridine calcium channel blocker like diltiazem is highly effective. Diltiazem provides adequate atrioventricular nodal blockade to control atrial fibrillation without the profound blunting of exercise capacity typically seen with beta-blockers. Amiodarone and sotalol are rhythm control agents with significant long-term toxicity profiles and are inappropriate for simple rate control in an otherwise healthy patient. Digoxin is ineffective at controlling the heart rate during the high sympathetic surge of intense exercise, making it a poor choice for a marathon runner.
🔑 Key takeaway
Calcium channel blockers are preferred over beta-blockers for active patients experiencing severe exercise intolerance and fatigue.
